Equipment for single-cell genomics launched by Illumina and Bio-Rad

Illumina, Inc. and Bio-Rad Laboratories, Inc. today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response.

Single-cell analysis enables a deep view into the gene expression of individual cells to understand their functions in complex tissues. The solution delivers high-throughput sequencing of thousands of individual cells, traditionally a challenging, costly, and time consuming process. Human development and disease research, fields in which single-cell sequencing is widely applicable, is expected to benefit most from this new offering.

“Single-cell genomics provides the opportunity to look at stem cells turning into neurons that are lost in diseases like Parkinson’s and amyotrophic lateral sclerosis (also known as Lou Gehrig's disease) with much higher accuracy,” said Clive Svendsen, PhD, Director, Cedars-Sinai Board of Governors Regenerative Medicine Institute in Los Angeles. His laboratory tested the application of the new platform to profile single cells used in modeling neurodegenerative diseases.

“Using the solution made it possible to detect single cells in a population that was maturing faster than others, allowing us to produce better models of disease,” added Ritchie Ho, PhD, Project Scientist in the Cedars-Sinai Board of Governors Regenerative Medicine Institute and lead researcher for the testing.

The solution comprises the ddSEQ™ Single-Cell Isolator and SureCell™ WTA 3' Library Prep Kit. Bio-Rad’s best-in-class droplet partitioning technology, Droplet Digital™ technology, is used to isolate and barcode single cells for downstream sequencing on many of Illumina’s leading NGS instruments.

The comprehensive workflow solution includes primary and secondary data analysis conducted via the BaseSpace® Informatics Suite, Illumina’s cloud-based genomics computing environment, and tertiary data analysis and visualization with SeqGeq™ from FlowJo, LLC, the market leader in flow cytometry analysis.

Through our close collaboration with Illumina we developed a seamless and scalable solution for single-cell analysis. We are proud to equip cell biologists and others in the research community with the tools they need to power new discovery.”

Annette Tumolo, Bio-Rad Executive Vice President and General Manager, Digital Biology Group.

“By offering cell biologists access to technologies that make single-cell analysis cost effective and easy to adopt, we hope to enable scientists to advance complex disease research using gene expression insights,” said Rob Brainin, Vice President and General Manager, Applied Genomics at Illumina. “Our collaboration with Bio-Rad has allowed us to bring this technology to market quickly and empower our customers to unlock the power of the genome to improve human health.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2017, January 12). Equipment for single-cell genomics launched by Illumina and Bio-Rad. News-Medical. Retrieved on October 03, 2024 from https://www.news-medical.net/news/20170112/Equipment-for-single-cell-genomics-launched-by-Illumina-and-Bio-Rad.aspx.

  • MLA

    Illumina, Inc.. "Equipment for single-cell genomics launched by Illumina and Bio-Rad". News-Medical. 03 October 2024. <https://www.news-medical.net/news/20170112/Equipment-for-single-cell-genomics-launched-by-Illumina-and-Bio-Rad.aspx>.

  • Chicago

    Illumina, Inc.. "Equipment for single-cell genomics launched by Illumina and Bio-Rad". News-Medical. https://www.news-medical.net/news/20170112/Equipment-for-single-cell-genomics-launched-by-Illumina-and-Bio-Rad.aspx. (accessed October 03, 2024).

  • Harvard

    Illumina, Inc.. 2017. Equipment for single-cell genomics launched by Illumina and Bio-Rad. News-Medical, viewed 03 October 2024, https://www.news-medical.net/news/20170112/Equipment-for-single-cell-genomics-launched-by-Illumina-and-Bio-Rad.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Illumina signs initial customer deals for new Global Screening Array